ArticleMolecular medicine (Cambridge, Mass.)2025

COX-2 inhibition as a therapeutic strategy for bone loss in Staphylococcus aureus osteomyelitis.

Yuhui Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.